SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-22T11:09:42.515872+00:00","dedupe_key":"signal_enriched:discovery_options_flow_delta:d884618f3ea18aa8","evidence_event_ids":["evt_a0aad8393e75"],"signal_type":"discovery_options_flow_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","as_of":"2026-04-22T11:09:42.515872+00:00","canonical_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","article_chars":3465,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4a3c4cb8777c201f","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-22T11:10:31.531810+00:00","extraction_method":"trafilatura","fetched_description":"FBDIX, VGHCX and FSPHX stand out as top healthcare mutual funds, offering diversification, steady demand exposure and solid long-term returns.","fetched_title":"3 Top-Ranked Healthcare Mutual Funds to Strengthen Your Portfolio | Nasdaq","final_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio","source_event_id":"evt_a0aad8393e75","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"761e46f73affc682","kind":"options_flow","published_at":"2026-04-22T09:18:00+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["October 2008","end of October 2025"],"entities":[{"asset_class":"mutual_fund","name":"Franklin Strategic Biotechnology Discovery Fund","relevance":"high","symbol":"FBDIX","type":"mutual_fund"},{"asset_class":"mutual_fund","name":"Vanguard Specialized Portfolios Health Care Fund","relevance":"high","symbol":"VGHCX","type":"mutual_fund"},{"asset_class":"mutual_fund","name":"Fidelity Select Health Care Fund","relevance":"high","symbol":"FSPHX","type":"mutual_fund"},{"asset_class":"equity","name":"Gilead Sciences","relevance":"medium","symbol":"","type":"equity_holding"}],"event_type":"other","information_gaps":["No options-flow data is present in the provided text (no calls vs puts, no expiry dates, no open-interest figures, no flow size, and no tickers tied to options).","The signal type indicates options-flow delta, but the article content is about mutual funds; therefore, options-flow fields cannot be grounded from the text.","No explicit statement is provided about whether any options-flow suggests informed positioning."],"key_facts":["The article names three healthcare mutual funds: FBDIX, VGHCX, and FSPHX.","Each fund is described as having a Zacks Mutual Fund Rank #1 (Strong Buy) and being expected to outperform peers.","FBDIX three-year annualized returns are stated as 23.9%.","As of the end of October 2025, FBDIX held 76 issues and 5.6% of its assets were invested in Gilead Sciences.","VGHCX three-year annualized returns are stated as 5.9%.","VGHCX expense ratio is stated as 0.33%.","FSPHX three-year annualized returns are stated as 5.3%.","The article states Edward Yoon has been the fund manager of FSPHX since October 2008."],"numeric_claims":[{"label":"FBDIX three-year annualized returns","value":"23.9%"},{"label":"FBDIX issues held (as of end of October 2025)","value":"76"},{"label":"FBDIX Gilead Sciences asset allocation (as of end of October 2025)","value":"5.6%"},{"label":"VGHCX three-year annualized returns","value":"5.9%"},{"label":"VGHCX expense ratio","value":"0.33%"},{"label":"FSPHX three-year annualized returns","value":"5.3%"}],"primary_claim":"Franklin Strategic Biotechnology Discovery Fund (FBDIX), Vanguard Specialized Portfolios Health Care Fund (VGHCX), and Fidelity Select Health Care Fund (FSPHX) are presented as Zacks Mutual Fund Rank #1 healthcare mutual funds expected to outperform peers, with provided three-year annualized return figures.","relevance_score":0.25,"sentiment":"positive","source_quality":"high","summary":"The article is a mutual-fund roundup highlighting three healthcare mutual funds (FBDIX, VGHCX, FSPHX) with Zacks Mutual Fund Rank #1 ratings and stated long-term performance metrics. It does not provide any options-flow (calls/puts), expiry, or open-interest context despite the signal type being options-flow related.","topics":["healthcare sector","mutual funds","Zacks Mutual Fund Rank #1","biotechnology","pharmaceuticals","fund performance","expense ratio"]},"source":"Nasdaq Investing","source_domain":"nasdaq.com","summary":"FBDIX, VGHCX and FSPHX stand out as top healthcare mutual funds, offering diversification, steady demand exposure and solid long-term returns.","tickers":[],"title":"3 Top-Ranked Healthcare Mutual Funds to Strengthen Your Portfolio","url":"https://www.nasdaq.com/articles/3-top-ranked-healthcare-mutual-funds-strengthen-your-portfolio"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 480810 in events